390 related articles for article (PubMed ID: 14973947)
1. Treatment of latent tuberculosis infection in HIV infected persons.
Woldehanna S; Volmink J
Cochrane Database Syst Rev; 2004; (1):CD000171. PubMed ID: 14973947
[TBL] [Abstract][Full Text] [Related]
2. Treatment of latent tuberculosis infection in HIV infected persons.
Akolo C; Adetifa I; Shepperd S; Volmink J
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD000171. PubMed ID: 20091503
[TBL] [Abstract][Full Text] [Related]
3. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
Gray DM; Zar H; Cotton M
Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
[TBL] [Abstract][Full Text] [Related]
4. Drugs for preventing tuberculosis in HIV infected persons.
Wilkinson D
Cochrane Database Syst Rev; 2000; (4):CD000171. PubMed ID: 11034676
[TBL] [Abstract][Full Text] [Related]
5. Drugs for preventing tuberculosis in HIV infected persons.
Wilkinson D
Cochrane Database Syst Rev; 2000; (2):CD000171. PubMed ID: 10796501
[TBL] [Abstract][Full Text] [Related]
6. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
[TBL] [Abstract][Full Text] [Related]
7. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007545. PubMed ID: 23828580
[TBL] [Abstract][Full Text] [Related]
8. Isoniazid for preventing tuberculosis in HIV-infected children.
Zunza M; Gray DM; Young T; Cotton M; Zar HJ
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006418. PubMed ID: 28850172
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid for preventing tuberculosis in non-HIV infected persons.
Smieja MJ; Marchetti CA; Cook DJ; Smaill FM
Cochrane Database Syst Rev; 2000; 1999(2):CD001363. PubMed ID: 10796642
[TBL] [Abstract][Full Text] [Related]
10. Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials.
Ayele HT; Mourik MS; Debray TP; Bonten MJ
PLoS One; 2015; 10(11):e0142290. PubMed ID: 26551023
[TBL] [Abstract][Full Text] [Related]
11. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.
Mwinga A; Hosp M; Godfrey-Faussett P; Quigley M; Mwaba P; Mugala BN; Nyirenda O; Luo N; Pobee J; Elliott AM; McAdam KP; Porter JD
AIDS; 1998 Dec; 12(18):2447-57. PubMed ID: 9875583
[TBL] [Abstract][Full Text] [Related]
12. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1997 Sep; 46(RR-15):1-10. PubMed ID: 9332982
[TBL] [Abstract][Full Text] [Related]
13. Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.
Johnson JL; Okwera A; Hom DL; Mayanja H; Mutuluuza Kityo C; Nsubuga P; Nakibali JG; Loughlin AM; Yun H; Mugyenyi PN; Vernon A; Mugerwa RD; Ellner JJ; Whalen CC;
AIDS; 2001 Nov; 15(16):2137-47. PubMed ID: 11684933
[TBL] [Abstract][Full Text] [Related]
14. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
Halsey NA; Coberly JS; Desormeaux J; Losikoff P; Atkinson J; Moulton LH; Contave M; Johnson M; Davis H; Geiter L; Johnson E; Huebner R; Boulos R; Chaisson RE
Lancet; 1998 Mar; 351(9105):786-92. PubMed ID: 9519950
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.
Dedicoat M; Vaithilingum M; Newton R
Cochrane Database Syst Rev; 2003; (3):CD003256. PubMed ID: 12917957
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective.
Bell JC; Rose DN; Sacks HS
AIDS; 1999 Aug; 13(12):1549-56. PubMed ID: 10465080
[TBL] [Abstract][Full Text] [Related]
18. Preventive therapy for tuberculosis in HIV infection: the promise and the reality.
O'Brien RJ; Perriëns JH
AIDS; 1995 Jul; 9(7):665-73. PubMed ID: 7546409
[TBL] [Abstract][Full Text] [Related]
19. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.
Whalen CC; Johnson JL; Okwera A; Hom DL; Huebner R; Mugyenyi P; Mugerwa RD; Ellner JJ
N Engl J Med; 1997 Sep; 337(12):801-8. PubMed ID: 9295239
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
